|
|
 |
|
| |
 |
Drug-like Properties in Drug Discovery |
|
| Course Code: DGLK |
|
 |
This course is designed to increase your knowledge of drug-like properties, ADME and how to apply this information in medicinal chemistry for hit selection, lead optimization and development candidate selection and is designed for medicinal chemists and other discovery scientists who design, synthesize, and test new drug candidates, lead research teams, or measure and predict ADMET properties of compounds.
Registrants will need to purchase a copy of the book, Drug-Like Properties: Concepts, Structure Design and Methods: From ADME to Toxicology, in addition to their registration as part of this course. To purchase this book at a discount through ACS, please contact Andrea Adams. Quantities are limited. |
|
| |
 |
| |
 |
|
| |
| |
| |
Dates - TBA |
| |
Check-in opens at 7:30 a.m. on the first day of the course.
Course runs from 8:30 a.m. to 5:00 p.m. each day. |
| |
| |
Event Location: |
| |
TBA |
| |
|
| |
| |
|
| |
|
 |
| |
|
| |
| |
Early Registration: |
$1,295 |
|
| |
Advanced Registration: |
$1,395 |
|
| |
Standard Registration: |
$1,495 |
|
| |
| |
The course fee includes a course binder and a continental breakfast each day.
Five for Four! Register five people for one course, one person for five courses, or any combination in between and your fifth registration is free. Note: This discount is only available if you register by fax or mail and mention this discount. May not be combined with any other offer. |
|
| |
|
|
|
|
|
| |
- Essentials of key pharmaceutical properties and practical real-world applications.
- Successful structure modification strategies to improve drug-like properties and pharmacokinetics.
- Case studies on how med chemists enhance properties and PK through structure modification.
- The impact of drug properties on drug discovery chemistry, in vitro and in vivo biological testing, pharmacokinetics, and safety.
- Property assays: experimental design, measurement and interpretation.
- Which properties to optimize for improved pharmacokinetics performance.
|
|
| |
| Edward H. Kerns is Associate Director of Chemical Technologies in Drug Discovery at Wyeth Research and teaches Drug-like Properties in Drug Discovery. |
| |
| Li Di is Principal Research Scientist II in Chemical Technologies in Drug Discovery at Wyeth Research and teaches Drug-like Properties in Drug Discovery. |
| |
|
|
){kind=link}